Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors

Abstract: The X-ray structure of the catalytic domain of the EphA3 tyrosine kinase in complex with a previously reported type II inhibitor was used to design two novel quinoxaline derivatives, inspired by kinase inhibitors that have reached clinical development. These two new compounds were characterized by an array of cell-based assays and gene expression profiling experiments. A global chemical proteomics approach was used to generate the drug-protein interaction profile, which suggested suitable therapeutic indications. Both inhibitors, studied in the context of angiogenesis and in vivo in a relevant lymphoma model, showed high efficacy in the control of tumor size

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch
Notes
RSC medicinal chemistry. - 11, 6 (2020) , 665-675, ISSN: 2040-2511

Event
Veröffentlichung
(where)
Freiburg
(who)
Universität
(when)
2020
Creator
Unzue, Andrea
Jessen-Trefzer, Claudia
Spiliotopoulos, Dimitrios
Gaudio, Eugenio
Tarantelli, Chiara
Dong, Jing
Zhao, Hongtao
Pachmayr, Johanna
Zahler, Stefan
Bernasconi, Elena
Sartori, Giulio
Cascione, Luciano
Bertoni, Francesco
Śledź, Paweł
Caflisch, Amedeo
Nevado Blázquez, Cristina

DOI
10.1039/D0MD00049C
URN
urn:nbn:de:bsz:25-freidok-1665457
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:45 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

Time of origin

  • 2020

Other Objects (12)